Prof. Dr. med. Matthias Eiber

radiology, nuclear medicine, theranostics and radiopharmaceuticals

User Score	Experience	Rating	Price Range	Publications	Media Files	Online Consultations
99%	19 years	9.8/10	$$$$	385	3	No

Overview

Country, City

Germany, Munich

Health facility

University Hospital Rechts der Isar Munich

Medical unit

Section for theranostics

About the doctor

Prof. Dr. med. Matthias Eiber is an extraordinary professor with many years of experience in radiology, nuclear medicine, and theranostics. He is known for his groundbreaking work in molecular imaging and personalized cancer therapy. His scientific publications focus on prostate cancer risk assessment and treatment optimization using innovative imaging techniques. Dr. Eiber's expertise has earned him prestigious awards, including the Dagobert Nitz Prize and recognition as a "highly cited researcher. " He currently leads the Theranostics Section at University Hospital Rechts der Isar Munich, where he continues to push the boundaries of oncological imaging and treatment. Dr. Matthias Eiber's impressive career includes training at renowned institutions like UCLA and leadership in research projects funded by reputable organizations like the DFG. His commitment to advancing nuclear medicine is evident in his role as a member of committees shaping the future of oncological imaging. Patients seeking cutting-edge diagnostics and personalized cancer care benefit from Dr. Eiber's expertise and dedication to improving outcomes through innovative theranostic approaches.

Skills & Expertise

Gallery

LACNETS - "GA68 Scan" Dr. Matthias Eiber

Resume

CV (Curriculum Vitae)

Education

2000-2006 Studied human medicine at the University of Regensburg with stays abroad at the universities in Vermont, Auckland and California San Diego
2006 Medical state examination and license to practice medicine
2003-2007 Doctorate at the Institute of Pathology, University of Regensburg (Prof. Dr. Arndt Hartmann): “Molecular characterization of inverted growing benign (inverted papillomas) and malignant (inverted urothelial carcinomas) urothelial tumors”, grade: “summa cum laude”
2007-2015 Further training as a specialist in radiology and nuclear medicine at the Institute for Diagnostic and Interventional Radiology and the Clinic for Nuclear Medicine, Klinikum rechts der Isar, TU Munich
2012 Habilitation and Venia legendi in Radiology, TU Munich
2019 2nd place on the list, W3 Nuclear Medicine, University of Augsburg
2020 2nd place on the list, W3 Nuclear Medicine, University of Düsseldorf

Experience

2013-2015 Senior physician for hybrid imaging (PET/CT and PET/MR)
2015-2019 Senior Physician, Department of Nuclear Medicine, Klinikum rechts der Isar, TU Munich
2016-2017 Assistant Professor at the Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, David Geffen School of Medicine at UCLA , Los Angeles, USA (Prof. Dr. Johannes Czernin)
2017-2021 Project leader, subproject B11 of the SFB 824 of the DFG (Imaging for selection, monitoring and individualization) ization of cancer therapy)
2019 Appointment as extraordinary professor at the Technical University of Munich
2020 Head of the Theranostics Section at the Clinic and Polyclinic for Nuclear Medicine

Awards & Memberships

Expert reviewers for research funding organizations, e.g. DFG, KWF, SNSF, INCA, FWF
Expert reviewer for journals e.g. Lancet Oncology, Clinical Cancer Research, EJNMMI, JNM, European Urology, Journal of Clinical Oncology, PLOS One, Theranostics
Member of the “Oncology & Theranostics Committee” of the EANM
Member of the Therapy Committee of the DGN
2015 Award of the Berlin-Brandenburg Society for Nuclear Medicine
2017 Dagobert Nitz Prize of the German Society for Nuclear Medicine for work in the field of theranostics with PSMA ligands in prostate cancer
2017 Alpine Countries Prize of the joint annual meeting of the German, Austrian and Swiss Societies for Nuclear Medicine
2020 “highly cited researcher” of the Web of Science